drugset / Trial / NCT02073773

Combinational Rehabilitative Therapy and Functional Brain Imaging for Patients Recovering From Motor Stroke

NCT02073773

RandomizedParallel-groupSingle-blindTreatment

Summary

The present proposal aims to assess whether a combined rehabilitation approach using virtual reality based therapy with motivational feedback, levodopa for pharmacotherapy and standard rehabilitative occupational therapy and physiotherapy will lead to signifcantly better outcomes for stroke recovery. It is a randomised controlled trial with blinding of the assessors only. It will be preceeded by a Phase 1 pilot trial of the VR physiotherapy and standard therapy only. Recruited in-patient rehabilitation ward patients who have recently suffered stroke will be randomized, through a computer-based random number generator, to either one of two treatment arms: 1. Control occupational therapy + pharmacotherapy for 2 weeks 2. Assisted Virtual-Reality physiotherapy + pharmacotherapy for 2 weeks

Timeline

Start
2014-01
Primary completion
2015-11
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Levodopa Small molecule 100 mg Oral

Indications